Current Report Filing (8-k)
June 28 2017 - 12:27PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
June
28, 2017 (June 28, 2017)
Commission
File #:
000-53723
TAURIGA
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Florida
(State
or other jurisdiction of incorporation)
65-1102237
(IRS
Employer Identification Number)
39
Old Ridgebury Road
Danbury,
CT 06180
(Address
of principal executive office)
Tel:
(917) 796-9926
(Registrant’s
telephone number)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
|
Item
5.07 — Submission of Matters to a Vote of Security Holders.
On
June 28, 2017, Tauriga Sciences, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”).
At the Special Meeting, there were 906,096,759 shares of common stock represented in person or by proxy of the 1,804,172,789 shares
of common stock entitled to be cast, constituting a quorum. Of the shares of common stock cast, a majority of the shares needed
to vote for the proposal for approval. As such, the Company’s stockholders approved the sole proposal listed below, which
proposal is described in detail in the Company’s definitive proxy statement for the Special Meeting filed with the Securities
and Exchange Commission on May 26, 2017. The final vote on the proposal presented at the Special Meeting is as follows:
Proposal
1: To approve an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of common
stock of the Company from 2,500,000,000 shares to 7,500,000,000 shares.
Votes
For
|
|
Votes
Against
|
|
Votes
Abstaining
|
865,768,668
|
|
25,173,588
|
|
15,154,503
|
ITEM
9.01 – FINANCIAL STATEMENTS AND EXHIBITS.
99.1
|
Press release dated June 28, 2017.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
June 28, 2017
|
|
|
TAURIGA
SCIENCES, INC.
|
|
|
|
By:
|
/s/
Seth M. Shaw
|
|
|
Seth
M. Shaw
|
|
|
Chief
Executive Officer
|
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2023 to Apr 2024